ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Colorectal Cancer
Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis
Melanoma

Non-Small-Cell Lung Cancer trials near Dallas, TX, USA:

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Fort Worth, Texas, United States and 210 other locations

Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...

Enrolling
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Livmoniplimab

Phase 2, Phase 3

AbbVie
AbbVie

Plano, Texas, United States and 61 other locations

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Durvalumab
Procedure: Surgery

Phase 3

AstraZeneca
AstraZeneca

Fort Worth, Texas, United States and 230 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...

Enrolling
Non-Small Cell Lung Cancer
Drug: Telisotuzumab Vedotin

Phase 2

AbbVie
AbbVie

Dallas, Texas, United States and 77 other locations

Locations recently updated

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

Fort Worth, Texas, United States and 311 other locations

(Robotic-Assisted Thoracoscopic Surgery) resection of Stage I-II non-small cell lung cancer (NSCLC)....

Enrolling
Non Small Cell Lung Cancer (NSCLC)
Drug: LS301-IT 0.1 mg/kg

Phase 2

Integro Theranostics

Dallas, Texas, United States and 1 other location

This is a phase 1, multicenter, open-label, first-in-human study of YL202 conducted in the United States and China.The study will evaluate the safety...

Active, not recruiting
Breast Cancer
Non Small Cell Lung Cancer
Drug: YL202

Phase 1

MediLink Therapeutics

Irving, Texas, United States and 12 other locations

study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Non...

Not yet enrolling
Non-Small Cell Lung Cancer
Drug: VS-7375

Phase 2

Verastem

Fort Worth, Texas, United States and 2 other locations

advanced or metastatic NSCLC.The study consists of 4 cohorts in participants with locally advanced or metastatic NSCLC ( squamous \[sq\] or non...

Enrolling
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Drug: ILKN421H
Drug: Pembrolizumab

Phase 2

iLeukon Therapeutics, Inc.

Fort Worth, Texas, United States and 1 other location

(pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-small cell lung...

Enrolling
Carcinoma, Non-Small-Cell Lung (NSCLC)
Lung Cancer
Biological: Pembrolizumab
Biological: PF-08634404

Phase 3

Pfizer
Pfizer

Dallas, Texas, United States and 371 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems